ABBV · AbbVie, Inc.
255.25
USDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
US$449.63B
PE
96.80
EV/EBITDA
16.1
DIV Yield
2.9%
Payout Ratio
200%
MQV Rating
3Neutral
As at 21/07/2026 10:36:02 AM
Price Chart
Description
- All-Companies
- All-Consensus
- ALL-Recommendations
- Engulfing Bearish
- HALO 200
- HALO 500
- HALO All
- HALO Capital Efficiency
- HALO Price Momentum
- Hammer Bearish
- Near Resistance (Realtime)
- Recent Price upgrade
Key Fundamentals
EPS 3 yr Growth
-64.40%
EBITDA Margin
47.50%
Operating Cashflow
$19,030m
Free Cash Flow Return
31.50%
ROIC
6.90%
Interest Coverage
9.50
Quick Ratio
0.60
Performance
52 weeks range
Low 184.63 - 261.64
Trade Value (12mth)
US$352,662,554.00
1 week
2.58%
1 month
15.03%
YTD
10.98%
1 year
34.47%
All time high
261.64
Additional Data
Shares Outstanding (Fully Diluted)
1,769m
HALO Sector
Healthcare
Next Company Report Date
03-Feb-27
Next Ex Dividend Date
15-Jul-26
Next Dividend Pay Date
14-Aug-26
Reporting Currency
USD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Neutral
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Strong
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Strong
Balance Sheet
Weak
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
07 July 26EDG | |
07 July 26EDG | |
25 June 26EDG | |
22 June 26EDG | |
13 May 26EDG |
